Oncoclinicas receives IG4 indicative offer for R$ 500 million convertible debentures amid restructuring talks

• Oncoclinicas received a non-binding indicative offer from IG4 on July 15, 2026 tied to its financial restructuring.
• Proposal contemplates subscription of debêntures conversíveis em ações totaling BRL 500 million.
• Offer also includes creating a usufruto over company shares, subject to shareholder-base agreement and other conditions precedent.
• No acceptance or commitment; no defined transaction with IG4 or any other party.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncoclinicas do Brasil Servicos Medicos SA published the original content used to generate this news brief on July 15, 2026, and is solely responsible for the information contained therein.